# Howard Hughes Holdings Inc.: financial statements, quarterly

HHH · NYSE · CIK 1981792 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hhh.md) · [Financials](/companies/hhh/financials.md) · [Filings](/companies/hhh/filings.md) · [Insiders](/companies/hhh/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hhh/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [228](/filings/0001628280-25-008128.md) | [313](/filings/0001628280-25-008128.md) | [156](/filings/0001628280-26-009710.md) | [283](/filings/0001628280-26-009710.md) | [327](/filings/0001628280-26-009710.md) | [984](/filings/0001628280-26-009710.md) | [199](/filings/0001628280-26-032144.md) | [261](/filings/0001628280-26-053324.md) | [390](/filings/0001981792-25-000011.md) | [624 d](/filings/0001628280-26-009710.md) | [236](/filings/0001628280-26-032144.md) | [1,122](/filings/0001628280-26-053324.md) |
| Operating income | $m | [59.4](/filings/0001628280-25-008128.md) | [105](/filings/0001628280-25-008128.md) | [12.6](/filings/0001628280-26-009710.md) | [88.5](/filings/0001628280-26-009710.md) | [198](/filings/0001628280-26-009710.md) | [261](/filings/0001628280-26-009710.md) | [47.9](/filings/0001628280-26-032144.md) | [67.9](/filings/0001628280-26-053324.md) | [190](/filings/0001981792-25-000011.md) | [26.2 d](/filings/0001628280-26-009710.md) | [50.7](/filings/0001628280-26-032144.md) | [240](/filings/0001628280-26-053324.md) |
| Interest expense | $m | [38.6](/filings/0001628280-23-037021.md) | [46.3 d](/filings/0001628280-24-007207.md) | [41.9](/filings/0001628280-24-021667.md) | [39.6](/filings/0001981792-25-000008.md) | [43.8](/filings/0001981792-25-000011.md) | [42.3 d](/filings/0001628280-26-009710.md) | [41.1](/filings/0001628280-26-032144.md) | [43.7](/filings/0001628280-26-053324.md) | [43.9](/filings/0001981792-25-000011.md) | [41.3 d](/filings/0001628280-26-009710.md) | [41.8](/filings/0001628280-26-032144.md) | [45.8](/filings/0001628280-26-053324.md) |
| Income tax | $m | [11.4](/filings/0001628280-24-044991.md) | [15.4 d](/filings/0001628280-26-009710.md) | [(6.5)](/filings/0001628280-25-023135.md) | [13.5](/filings/0001981792-25-000008.md) | [10.2](/filings/0001981792-25-000011.md) | [62.9 d](/filings/0001628280-26-009710.md) | [3.4](/filings/0001628280-26-032144.md) | [(3.8)](/filings/0001628280-26-053324.md) | [38.9](/filings/0001981792-25-000011.md) | [(0.9) d](/filings/0001628280-26-009710.md) | [2.6](/filings/0001628280-26-032144.md) | [50.0](/filings/0001628280-26-053324.md) |
| Net income | $m | [(544)](/filings/0001628280-25-008128.md) | [34.3](/filings/0001628280-25-008128.md) | [(52.5)](/filings/0001628280-26-009710.md) | [21.1](/filings/0001628280-26-009710.md) | [72.8](/filings/0001628280-26-009710.md) | [156](/filings/0001628280-26-009710.md) | [10.5](/filings/0001628280-26-032144.md) | [(12.1)](/filings/0001628280-26-053324.md) | [120](/filings/0001981792-25-000011.md) | [6.0 d](/filings/0001628280-26-009710.md) | [8.2](/filings/0001628280-26-032144.md) | [158](/filings/0001628280-26-053324.md) |
| Diluted EPS | $ per share | [(10.96)](/filings/0001628280-25-008128.md) | [0.69](/filings/0001628280-25-008128.md) | [(1.06)](/filings/0001628280-26-009710.md) | [0.42](/filings/0001628280-26-009710.md) | [1.46](/filings/0001628280-26-009710.md) | [3.12](/filings/0001628280-26-009710.md) | [0.21](/filings/0001628280-26-032144.md) | [(0.22)](/filings/0001628280-26-053324.md) | [2.02](/filings/0001981792-25-000011.md) | not reported | [0.14](/filings/0001628280-26-032144.md) | [2.68](/filings/0001628280-26-053324.md) |
| Basic EPS | $ per share | [(10.97)](/filings/0001628280-25-008128.md) | [0.69](/filings/0001628280-25-008128.md) | [(1.06)](/filings/0001628280-26-009710.md) | [0.42](/filings/0001628280-26-009710.md) | [1.46](/filings/0001628280-26-009710.md) | [3.15](/filings/0001628280-26-009710.md) | [0.21](/filings/0001628280-26-032144.md) | [(0.22)](/filings/0001628280-26-053324.md) | [2.03](/filings/0001981792-25-000011.md) | not reported | [0.14](/filings/0001628280-26-032144.md) | [2.68](/filings/0001628280-26-053324.md) |

- Revenue: us-gaap:Revenues
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.5](/filings/0001628280-24-044991.md) | [0.6](/filings/0001628280-26-009710.md) | [0.5](/filings/0001628280-25-023135.md) | [0.4](/filings/0001981792-25-000008.md) | [0.4](/filings/0001981792-25-000011.md) | [0.6](/filings/0001628280-26-009710.md) | [0.5](/filings/0001628280-26-032144.md) | [1.4](/filings/0001628280-26-053324.md) | [1.5](/filings/0001981792-25-000011.md) | [1.5](/filings/0001628280-26-053324.md) | [1.8](/filings/0001628280-26-032144.md) | [2.6](/filings/0001628280-26-053324.md) |
| Total assets | $bn | [9.4](/filings/0001628280-23-037021.md) | [9.6](/filings/0001628280-25-008128.md) | [9.6](/filings/0001628280-24-021667.md) | [9.9](/filings/0001628280-24-033188.md) | [9.4](/filings/0001628280-24-044991.md) | [9.2](/filings/0001628280-26-009710.md) | [9.3](/filings/0001628280-25-023135.md) | [10.3](/filings/0001981792-25-000008.md) | [10.7](/filings/0001981792-25-000011.md) | [10.6](/filings/0001628280-26-053324.md) | [11.2](/filings/0001628280-26-032144.md) | [15.9](/filings/0001628280-26-053324.md) |
| Total liabilities | $bn | [6.3](/filings/0001628280-23-037021.md) | [6.5](/filings/0001628280-25-008128.md) | [6.6](/filings/0001628280-24-021667.md) | [6.9](/filings/0001628280-24-033188.md) | [6.8](/filings/0001628280-24-044991.md) | [6.4](/filings/0001628280-26-009710.md) | [6.4](/filings/0001628280-25-023135.md) | [6.6](/filings/0001981792-25-000008.md) | [6.9](/filings/0001981792-25-000011.md) | [6.8](/filings/0001628280-26-053324.md) | [7.4](/filings/0001628280-26-032144.md) | [10.9](/filings/0001628280-26-053324.md) |
| Long-term debt | $bn | not reported | [5.3](/filings/0001628280-24-007207.md) | not reported | not reported | not reported | [5.1](/filings/0001628280-25-008128.md) | not reported | not reported | not reported | [5.1](/filings/0001628280-26-009710.md) | not reported | not reported |
| Shareholders' equity | $bn | [3.0](/filings/0001628280-23-037021.md) | [3.0](/filings/0001628280-25-008128.md) | [2.9](/filings/0001628280-24-021667.md) | [3.0](/filings/0001628280-24-033188.md) | [2.6](/filings/0001628280-24-044991.md) | [2.8](/filings/0001628280-26-009710.md) | [2.8](/filings/0001628280-25-023135.md) | [3.6](/filings/0001981792-25-000008.md) | [3.8](/filings/0001981792-25-000011.md) | [3.8](/filings/0001628280-26-053324.md) | [3.8](/filings/0001628280-26-032144.md) | [4.0](/filings/0001628280-26-053324.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(109) d](/filings/0001628280-24-044991.md) | [101 d](/filings/0001628280-26-009710.md) | [(171)](/filings/0001628280-25-023135.md) | [(17.5) d](/filings/0001981792-25-000008.md) | [248 d](/filings/0001981792-25-000011.md) | [337 d](/filings/0001628280-26-009710.md) | [(225)](/filings/0001628280-26-032144.md) | [177 d](/filings/0001628280-26-053324.md) | [150 d](/filings/0001981792-25-000011.md) | [360 d](/filings/0001628280-26-009710.md) | [(229)](/filings/0001628280-26-032144.md) | [507 d](/filings/0001628280-26-053324.md) |
| Share repurchases | $m | not reported | [0.0 d](/filings/0001628280-25-008128.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | period not labelled (2022-09-30) | period not labelled (2023-03-31) | period not labelled (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [49.5](/filings/0001628280-23-037021.md) | [49.5](/filings/0001628280-24-021667.md) | [49.6](/filings/0001628280-24-033188.md) | [49.7](/filings/0001628280-24-044991.md) | [49.7](/filings/0001628280-25-023135.md) | [49.7](/filings/0001981792-25-000008.md) | [49.8](/filings/0001981792-25-000011.md) | [50.0](/filings/0001628280-26-032144.md) | [55.3](/filings/0001628280-26-053324.md) | [59.1](/filings/0001981792-25-000011.md) | [59.2](/filings/0001628280-26-032144.md) | [59.2](/filings/0001628280-26-053324.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 59,721,036 at 2026-07-29, from the cover of the [10-Q filed 2026-08-05](/filings/0001628280-26-053324.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.